Christopher E. Dandoy, MD, MSc

Member, Division of Bone Marrow Transplantation and Immune Deficiency
Associate Professor, UC Department of Pediatrics

christopher.dandoy@cchmc.org
Board Certified

Burnet Campus

Make An Appointment

Existing PatientsMyChart Scheduling

AppointmentsCall Us to ScheduleAppointments1-513-636-3200

About

Biography

I have always enjoyed caring for patients and their families, and I appreciate the unique bond that forms during treatment. But as a physician, I’ve experienced the devastating impact bloodstream infections can have on children. On more than one occasion, my team has successfully cured a child’s cancer using stem cell transplant, only to lose them later to a bloodstream infection.

As a result, my research focuses on identifying, testing and implementing clinical strategies to help improve outcomes after stem cell transplantation for malignancy. My clinical work compliments my research focus since I am the physician lead for the autologous stem cell transplant program, caring for many patients with leukemia. I prioritize patient safety, quality improvement, and the prevention of bloodstream infections and cardiopulmonary complications, such as pulmonary hypertension.

Cincinnati Magazine recognized me as a Top Doctor in 2019 and 2020. Also, our Cancer and Blood Diseases Institute Quality Improvement and Patient Safety team won the Ohio Patient Safety Institute’s Dr. Frank Dono Best Practice Award.

I am co-editor of the book Patient Safety and Quality in Pediatric Hematology/Oncology and Stem Cell Transplantation, published in 2017 by Springer. I’ve served in several local and national leadership roles, including the co-physician lead for the Solutions for Patient Safety (SPS) Pediatric Hematology-Oncology Central Line-Associated Bloodstream Infection (CLABSI) reduction collaboration.

I serve as the vice chair of the American Society of Transplant and Cellular Therapy (ASTCT) Committee on Quality Outcomes. I am co-chair of the Center for International Blood and Marrow Transplant Research (CIBMTR) Infection and Immune Reconstitution Working Committee.

Interests

Hematopoietic stem cell transplantation for children and young adults with malignancy or hemoglobinopathies

Services and Specialties

Research Areas

Quality Improvement (Anderson Center)

Additional Languages

Portuguese, Spanish

Location

Burnet Campus

3333 Burnet Ave
Cincinnati, OH 45229

Insurance Information

Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.

View Insurance Information

Publications

Engraft: A Collaborative Learning Health Network for Enhanced Transplant and Cellular Therapy Outcomes. Dandoy, CE; Auletta, JJ; Badia, P; Bidgoli, A; Daraiseh, NM; DeSalvo, AM; Diaz, J; Davies, SM; Demmel, K; Cook, E; Salem, BM; Snyder, A; Juckett, M; Hartley, D. Transplantation and Cellular Therapy. 2025; 31:123-134.

Oxidative Stress Early After Hematopoietic Stem Cell Transplant. Cook, E; Langenberg, L; Luebbering, N; Ibrahimova, A; Myers, KC; Sabulski, A; Dandoy, C; Lake, K; Ziady, A; Lane, A; Webster, A; Abdullah, S; Jodele, S; Davies, SM. Transplantation and Cellular Therapy. 2025; 31:135.e1-135.e10.

Characterizing the Gut Microbiome in Pediatric Patients Undergoing Hematopoietic Cell Transplant for a Non-Malignant Diagnosis. Verkamp, B; Dandoy, DC E; Badia, P; Haslam, D; Davies, SM; Khandelwal, P. Transplantation and Cellular Therapy. 2025; 31:s316-s317.

Nurse Driven Central Line Rounding Utilized to Improve Bone Marrow Transplant Patient Outcomes: An Update. Meyer, R; Orndorff, L; Engel, H; Hoback, P; Spivey, S; Mikut, K; Spears, K; Clark, A; Sarver, S; Dandoy, DC E. Transplantation and Cellular Therapy. 2025; 31:s451.

Variation in Central Venous Catheter Practices and Complications after Stem Cell Transplant: A Multi-Center Survey of the Engraft Learning Network. Sampson, M; Parker, L; Dandoy, DC E; Auletta, DJ J; Chapman, LR M; Cook, E; Craddock, J; Culbertson, C; Daraiseh, N; Diaz, J; Snyder, AJ; Staton, S; Wall, SA; Badia, P. Transplantation and Cellular Therapy. 2025; 31:s535-s536.

Inbody Assessments Reveal Important Changes in Body Mass Composition during HCT. Taggart, CB; Bota, KE; Young, K; Wall, J; Davies, SM; Dandoy, DC E; Ramos, KN. Transplantation and Cellular Therapy. 2025; 31:s146.

Acute Toxicities and Early Outcomes of Tandem Autologous Stem Cell Transplantation in Pediatric High-Risk Neuroblastoma: A Multicenter Study. Hudda, DZ; Schoettler, ML; Rotz, SJ; Kapadia, M; Lehmann, LE; Freedman, JL; Pater, L; Weiss, B; Badia, P; Davies, SM; Mormann, M; Desai, A; Webster, A; Dandoy, DC E. Transplantation and Cellular Therapy. 2025; 31:s93-s94.

The Tell-Tale Heart: A Cytokine Storm Story of Pericardial Effusions after HSCT. Koo, DJ; Webster, A; Dandoy, DC E; Jodele, S; Davies, SM; Sabulski, DA. Transplantation and Cellular Therapy. 2025; 31:s137.

The HCT Protein Shake: Moderate and Severe Proteinuria Are Specific to TA-TMA. Manjrekar, P; Sabulski, DA; Lies, E; Dandoy, DC E; Davies, SM; Laskin, B; Jodele, S. Transplantation and Cellular Therapy. 2025; 31:s145.

Pre-Transplant Complement Activation and Transplant-Associated Thrombotic Microangiopathy (TA-TMA) across Diagnostic Groups. Ramos, KN; Zee, J; Sabulski, DA; Laskin, B; Blackard, JT; Langenberg, L; Dandoy, DC E; Davies, SM; Jodele, S. Transplantation and Cellular Therapy. 2025; 31:s25-s26.

From the Blog

Cancer

For Children After Stem Cell Transplants, Food Timing Matters

Christopher E. Dandoy, MD, MSc, John Hogenesch, PhD2/15/2023

Patient Ratings and Comments

All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey

4.6

Overall Patient Rating